Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;178(22):4428-4439.
doi: 10.1111/bph.15619. Epub 2021 Aug 21.

Asthma: role of the angiotensin-(1-7)/Mas (MAS1) pathway in pathophysiology and therapy

Juliana Fabiana Gregório  1 , Maria da Gloria Rodrigues-Machado  2 , Robson Augusto Souza Santos  1 , Igor Antônio Carvalho-Ribeiro  2 , Olivia Mendonça Nunes  2 , Isabel Fusaro Aguiar Oliveira  2 , Ana Victoria de Oliveira Vasconcellos  2 , Maria Jose Campagnole-Santos  1 , Giselle Santos Magalhães  1   2
Affiliations
Free article
Review

Asthma: role of the angiotensin-(1-7)/Mas (MAS1) pathway in pathophysiology and therapy

Juliana Fabiana Gregório et al. Br J Pharmacol. 2021 Nov.
Free article

Abstract

The incidence of asthma is a global health problem and requires studies aimed for the development of new treatments to improve its clinical management, reducing personal and economic burdens on the health system. Therefore, the discovery of mediators that promote anti-inflammatory and pro-resolutive effects are highly desirable to improve lung function and quality of life of asthmatic patients. In that regard, experimental studies have shown that the angiotensin-(1-7)/Mas receptor (MAS1) of the renin-angiotensin system is a potential candidate for the treatment of asthma. Therefore, we have reviewed findings related to the function of the angiotensin-(1-7)/Mas pathway in regulating the processes associated with inflammation, including leukocyte influx, fibrogenesis, pulmonary dysfunction and the resolution of inflammation in asthma. Thus, a knowledge of the role of the angiotensin-(1-7)/Mas can help pave the way for the development of new treatments for this disease, which has high morbidity and mortality, through new types of experiments and clinical trials.

Keywords: allergic lung inflammation; eosinophils; neutrophils; pulmonary remodelling; renin-angiotensin system; resolution of inflammation.

PubMed Disclaimer

References

REFERENCES

    1. Abdel-Fattah, M. M., Salama, A. A., Shehata, B. A., & Ismaiel, I. E. (2015). The potential effect of the angiotensin II receptor blocker telmisartan in regulating OVA-induced airway remodeling in experimental rats. Pharmacological Reports: PR, 67(5), 943-951. https://doi.org/10.1016/j.pharep.2015.02.010
    1. Agata, J., Ura, N., Yoshida, H., Shinshi, Y., Sasaki, H., Hyakkoku, M., Taniguchi, S., & Shimamoto, K. (2006). Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme. Hypertension Research: Official Journal of the Japanese Society of Hypertension, 29, 865-874.
    1. Aggarwal, B., Mulgirigama, A., & Berend, N. (2018). Exercise-induced bronchoconstriction: Prevalence, pathophysiology, patient impact, diagnosis and management. NPJ Primary Care Respiratory Medicine, 28(1), 31. https://doi.org/10.1038/s41533-018-0098-2
    1. Alagappan, V. K., Willems-Widyastuti, A., Seynhaeve, A. L., Garrelds, I. M., ten Hagen, T. L., Saxena, P. R., & Sharma, H. S. (2007). Vasoactive peptides upregulate mRNA expression and secretion of vascular endothelial growth factor in human airway smooth muscle cells. Cell Biochemistry and Biophysics, 47, 109-118.
    1. Alam, R., & Gorska, M. M. (2011). Mitogen-activated protein kinase signalling and ERK1/2 bistability in asthma. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, 41, 149-159.

Publication types